Impact of Perceived Cognitive Impairment on Work-Related Outcomes in Breast Cancer Survivors

November 2017 Vol 8, No 11

Significance: Work is central for most adults in the United States, including women with breast cancer. More than 90% of breast cancer survivors (BCS) in the United States return to work following cancer treatment. Returning to work has been found to provide meaning and purpose in life and has been linked to overall sense of well-being for BCS. However, up to 30% of BCS report difficulty retuning to work due to lingering symptoms posttreatment. One symptom that has not received much attention in regard to work-related outcomes is perceived cognitive impairment. Current estimates suggest that anywhere from 30% to 75% of BCS report concerns with cognitive impairment after treatment.

Purpose: The purpose of this study was to examine the impact of perceived cognitive impairment on work-related outcomes, including work ability, work performance, and intent to turn over controlling for BCS characteristics (age, education, and time posttreatment), and emotional work demands.

Methods and Analysis: The cancer and work model by Feuerstein et al guided this cross-sectional, descriptive study. BCS who were employed and at least 1 year postadjuvant treatment completed questionnaires assessing perceived cognitive impairment (Functional Assessment of Cancer Therapy – Cognitive Subscale), emotional work demands (Self-Focused Emotional Labor Scale), work ability (Work Ability Index), work productivity (Work Limitations Questionnaire), and intent to turn over. Descriptive statistics and general linear regression were used.

Findings and Interpretation: 68 female BCS, ranging from 29 to 68 years of age (M = 52.1; SD = 8.6) and an average of 4.97 (SD = 3.36) years posttreatment, participated. Over one-fourth (26.5%) of BCS reported poor to moderate perceived work ability, indicating substantial concerns regarding work performance. Cognitive impairment predicted work ability (P <.000) and work productivity (P <.000), but not intent to turn over.

Discussion and Implications: Findings from this study improve our understanding regarding the impact of perceived cognitive impairment on work-related outcomes in BCS. Cognitive impairment is a common symptom reported by BCS. The growing set of options for treating breast cancer means that clinicians and patients will need to consider how best to balance the goals of treatment and risks to work once treatment is complete.

Innovation: This is one of the first studies to examine the impact of perceived cognitive impairment on work-related outcomes in BCS.

Note: This abstract was presented at the ONS 2017 Annual Conference as a podium presentation. Institutions involved are Indiana University and Indiana University Health North Hospital. This study was supported by a grant from the Walther Cancer Institute.

Related Articles
“Preparing” for Cancer: The Power of PREhab and Psycho-Oncology
May 2023 Vol 14, No 5
In the fall of 2013, Loriana Hernandez-Aldama was working as a high-profile health reporter and TV news anchor. She was fit, healthy, and busy with her career and 2-year-old son when acute bone pain woke her up in the middle of the night.
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country